CVS Enterprise Value Over E B I T D A from 2010 to 2024
| CVS Stock | USD 59.96 0.95 1.61% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 9.49788756 | Current Value 7.58 | Quarterly Volatility 3.28188492 |
Check CVS Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CVS Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.6 B, Interest Expense of 2.8 B or Selling General Administrative of 40.3 B, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.0243 or PTB Ratio of 1.26. CVS financial statements analysis is a perfect complement when working with CVS Health Valuation or Volatility modules.
CVS | Enterprise Value Over E B I T D A |
Latest CVS Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of CVS Health Corp over the last few years. It is CVS Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CVS Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
CVS Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 10.82 | |
| Geometric Mean | 10.45 | |
| Coefficient Of Variation | 30.32 | |
| Mean Deviation | 2.22 | |
| Median | 9.75 | |
| Standard Deviation | 3.28 | |
| Sample Variance | 10.77 | |
| Range | 12.9647 | |
| R-Value | 0.13 | |
| Mean Square Error | 11.41 | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | 0.09 | |
| Total Sum of Squares | 150.79 |
CVS Enterprise Value Over E B I T D A History
About CVS Health Financial Statements
CVS Health shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although CVS Health investors may analyze each financial statement separately, they are all interrelated. The changes in CVS Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on CVS Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 9.50 | 7.58 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.